Preview Mode Links will not work in preview mode

RIMScast


Jul 6, 2021

Welcome to RIMScast. Your host is Justin Smulison, Business Content Manager at RIMS, the Risk and Insurance Management Society.

 

COVID-19 remains a serious threat. On June 29th, 2021, the World Health Organization (WHO) reported that there have been 181,007,816 confirmed cases of COVID-19 globally, including 3,927,222 deaths. As of June 28th, 2021, a total of 2,660,756,547 vaccine doses have been administered.

 

This week, Dr. Adrian Hyzler, the Chief Medical Officer of Healix International, joins RIMScast once again to provide an update on current COVID-19 developments. He discusses the current WHO data; the new Delta variant that is causing major disruption in India, South Africa, the UK, and Australia; his outlook on herd immunity; and information around vaccine boosters in development. He also shares some insights around the long-haul symptoms of COVID-19, how these symptoms manifest both physically and mentally, and what risk professionals can continue to do to safely drive their organization’s reopenings.

 

Key Takeaways:

[:01] About RIMS’s Global Membership.

[:25] About today’s episode with Dr. Adrian Hyzler.

[:35] Upcoming RIMS Virtual Workshops and Webinars.

[2:05] More about today’s episode with Dr. Adrian Hyzler.

[2:55] Justin welcomes Dr. Hyzler back to RIMScast!

[3:01] What we need to know about the COVID-19 Delta variant and how it differs from the Alpha variant.

[5:25] How concerned should we be about the Delta Plus variant?

[6:54] Why boosters of the vaccines are in development.

[10:16] Dr. Hyzler’s outlook on herd immunity.

[13:24] Upcoming RIMS Virtual Workshops, volunteering opportunities, and resources.

[15:45] The long-haul symptoms of COVID-19 and what organizations can do for their employees that are impacted by this.

[21:57] Dr. Hyzler shares his thoughts on how he thinks the long-haul symptoms will impact long-term disability claims and whether insurance companies will accept or deny these claims. He also shares his thoughts on whether or not companies will extend the length of coverage for mental health disabilities in an effort to attract, retain, or accommodate their employees.

[22:53] What Dr. Hyzler feels are some of the best ways to re-emerge from the pandemic, from what companies have done correctly to what we can do as individuals.

[25:45] Has any science changed (around how COVID-19 spreads) since Dr. Hyzler’s last update?

[28:16] How long does Dr. Hyzler predict that we’ll be living our lives against the backdrop of COVID-19?

[30:24] Justin thanks Dr. Adrian Hyzler for joining RIMScast once again and shares some of the links to look out for in this episode’s show notes.

 

Mentioned in this Episode:

RIMS Events, Education, and Services:

Registration for the VIRTUAL Spencer & Gallagher Golf Tournament is now open! Visit SpencerEd.org for more information and to register through August 15th, 2021 (You choose the golf course and team all while continuing to support the Spencer Educational Foundation!)

Spencer’s Risk Manager on Campus Program — Volunteer Today!

Upcoming Webinars:

July 15, 2021 | “10 Essential Steps to Streamline Vendor Risk Assessments” | Sponsored by OneTrust

July 26, 2021 | RIMS and the RIMS Rocky Mountain Chapter Present: “A Discussion of Lloyd’s of London’s ESG Report 2020” — Open Exclusively to RIMS Members!

July 29, 2021 | How Better Data Is Transforming Risk Management & The Commercial Property Insurance Industry | Sponsored by Archipelago

Virtual Workshops:

Upcoming RIMS-CRMP Exam Prep Virtual Workshops (July & August 2021) — Gain an edge with the RIMS-CRMP; the only internationally accredited risk management certification!

RIMS Virtual Workshops: Claims Management — Register now for July 15‒16th, Aug. 23‒24th, or Nov. 8‒9th

RIMS Risk Appetite Management Virtual Workshop — July 21‒22nd

Save 15% off July and August Workshops! Use discount code LEARNRISK15 — Offer ends July 9th, 2021 (See the offer details below!)

RIMS Membership — Whether you are a new member or need to transition, be a part of the global risk management community!

RIMS Virtual Workshops

Upcoming RIMS Webinars

On-Demand Webinars

Previous Episodes with Dr. Adrian Hyzler:

COVID-19 Update with Dr. Adrian Hyzler of HX Global – January 2021

“An Update on COVID-19 with Dr. Adrian Hyzler Part 2” — Jun. 30th, 2020

“An Update on COVID-19 with Dr. Adrian Hyzler” — Jun. 23rd, 2020

“COVID-19 Update with Dr. Adrian Hyzler of HX Global” — Apr. 28th, 2020

“What Risk Professionals Should Know About the Coronavirus with Richard Lewis and Dr. Adrian Hyzler” — Feb. 18th, 2020

Download any episode of RIM cast.

RIMS Publications, Content, and Links:

RIMS Coronavirus Information Center

Risk Management Magazine

Risk Management Monitor

RIMS Risk Leaders Series — New episode with Cheryl Lloyd now available!

RIMS-Certified Risk Management Professional (RIMS-CRMP)

RIMS-CRMP Stories — New interview featuring former RIMS Vice President Steve Pottle

Spencer Educational Foundation

RIMS Diversity, Equity & Inclusion Council

 

Want to Learn More?

Keep up with the podcast on RIMS.org and listen on iTunes.

Have a question or suggestion? Email: Content@rims.org.

 

Join the Conversation!

Follow @RIMSorg on Facebook and Twitter, and LinkedIn.

 

Follow up with Our Guest:

Dr. Adrian Hyzler

 

Tweetables (For Social Media Use):

 

“The message is: get your vaccine and get the full course. And then you’re in a good position if the Delta takes over in your community, which it may well do.” — Dr. Adrian Hyzler

 

“Bear in mind, it’s not just Delta and Delta Plus; there’s Eta, and Theta, and Kappa, and Lambda — all these variants under investigation that are waiting in the wings. In all likelihood, we’ll go right through the alphabet before this is over.” — Dr. Adrian Hyzler

 

“I think there’s more confidence that immunity is going to last and that we’re not going to be doing this every year.” — Dr. Adrian Hyzler

 

“We’re now trying to move to a point where, instead of lots of trials going on everywhere, there’s more centralization of trials and … use of medication that we’ve proven. … [It’s] very important that next time we do use medication that we know works.” — Dr. Adrian Hyzler